Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination
暂无分享,去创建一个
M. Nussenzweig | P. Bieniasz | A. Gazumyan | B. Johnson | Thiago Y. Oliveira | T. Hatziioannou | C. Gaebler | F. Muecksch | F. Schmidt | M. Caskey | Raphael Raspe | I. Shimeliovich | Victor Ramos | Zijun Wang | Juan P Dizon | A. Cho | M. Cipolla | Kai-Hui Yao | Dennis J Schaefer-Babajew | Martina Turroja | Marie Canis | Justin DaSilva | Katrina G. Millard | Maximilian Loewe | L. Witte | Dennis J. Schaefer-Babajew
[1] M. Nussenzweig,et al. Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans , 2022, bioRxiv.
[2] D. Burton,et al. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses , 2022, Immunity.
[3] M. Nussenzweig,et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost , 2022, Nature.
[4] M. Nussenzweig,et al. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination , 2021, Nature.
[5] C. Rice,et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection , 2021, Nature.
[6] L. Stamatatos,et al. Germinal center–dependent and –independent memory B cells produced throughout the immune response , 2021, The Journal of experimental medicine.
[7] M. Nussenzweig,et al. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies , 2021, bioRxiv.
[8] M. Nussenzweig,et al. Sequencing, cloning, and antigen binding analysis of monoclonal antibodies isolated from single mouse B cells , 2021, STAR protocols.
[9] D. Burton,et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants , 2021, Science.
[10] M. Nussenzweig,et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants , 2021, bioRxiv.
[11] C. Rice,et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA , 2020, Science Translational Medicine.
[12] J. Beeson,et al. Epitope masking may limit antibody boosting to malaria vaccines , 2020, Immunology and cell biology.
[13] M. Nussenzweig,et al. Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates , 2020, Cell.
[14] M. Nussenzweig,et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies , 2020, Nature.
[15] S. Hoffman,et al. Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response. , 2020, Cell host & microbe.
[16] C. Rice,et al. Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.
[17] C. Rice,et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses , 2020, bioRxiv.
[18] M. Nussenzweig,et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies , 2020, bioRxiv.
[19] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[20] M. V. van Breemen,et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability , 2020, Science.
[21] Philip L. Felgner,et al. A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.
[22] M. Meyer-Hermann. Injection of Antibodies against Immunodominant Epitopes Tunes Germinal Centers to Generate Broadly Neutralizing Antibodies. , 2019, Cell reports.
[23] D. Irvine,et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques , 2019, Nature.
[24] James E. Crowe,et al. High frequency of shared clonotypes in human B cell receptor repertoires , 2019, Nature.
[25] A. Arrick,et al. Institutional Animal Care and Use Committee (IACUC) , 2018 .
[26] J. Ravetch,et al. Fcγ Receptor Function and the Design of Vaccination Strategies. , 2017, Immunity.
[27] M. Shlomchik,et al. Memory B Cells of Mice and Humans. , 2017, Annual review of immunology.
[28] Rustom Antia,et al. Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza , 2016, PLoS pathogens.
[29] M. Shlomchik,et al. A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells. , 2014, Immunity.
[30] Steven H. Kleinstein,et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data , 2015, Bioinform..
[31] T. Kurosaki,et al. Memory B cells , 2015, Nature Reviews Immunology.
[32] M. Jenkins,et al. A germinal center–independent pathway generates unswitched memory B cells early in the primary response , 2012, The Journal of experimental medicine.
[33] R. Maul,et al. Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response , 2011, Science.
[34] J. Desjarlais,et al. Enhanced antibody half-life improves in vivo activity , 2010, Nature Biotechnology.
[35] T. Phan,et al. High affinity germinal center B cells are actively selected into the plasma cell compartment , 2006, The Journal of experimental medicine.
[36] B. Heyman,et al. Regulation of antibody responses via antibodies, complement, and Fc receptors. , 2000, Annual review of immunology.
[37] K. Rajewsky,et al. Evidence for a large compartment of IgM-expressing memory B cells in humans. , 1997, Blood.
[38] Theobald. Smith. ACTIVE IMMUNITY PRODUCED BY SO CALLED BALANCED OR NEUTRAL MIXTURES OF DIPHTHERIA TOXIN AND ANTITOXIN , 1909, The Journal of experimental medicine.